Patents by Inventor Lukas Oberer

Lukas Oberer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aminoalkanol derivatives
    Patent number: 9415024
    Abstract: Disclosed are compounds of formula I wherein R1, R2, R5 and R6 are as defined in the claims; such compounds have interesting pharmacological properties.
    Type: Grant
    Filed: June 13, 2013
    Date of Patent: August 16, 2016
    Assignee: Novartis AG
    Inventors: Ernst Küsters, Lukas Oberer, Gottfried Sedelmeier
  • AMINOALKANOL DERIVATIVES
    Publication number: 20130289127
    Abstract: Disclosed are compounds of formula I wherein R1, R2, R5 and R6 are as defined in the claims; such compounds have interesting pharmacological properties.
    Type: Application
    Filed: June 13, 2013
    Publication date: October 31, 2013
    Inventors: Ernst Küsters, Lukas Oberer, Gottfried Sedelmeier
  • Aminoalkanol Derivatives
    Publication number: 20080161410
    Abstract: Disclosed are compounds of formula I wherein R1, R2, R5 and R6 are as defined in the claims; such compounds have interesting pharmacological properties.
    Type: Application
    Filed: October 14, 2004
    Publication date: July 3, 2008
    Inventors: Ernst Kusters, Lukas Oberer, Gottfried Sedelmeier
  • Epothilone derivatives
    Patent number: 7317100
    Abstract: The present invention relates to C4-demethyl-epothilones or C4-bisnor-epothilones of Formula (I), their pharmaceutical use, pharmaceutical composition containing the same and methods for their preparation.
    Type: Grant
    Filed: December 22, 2003
    Date of Patent: January 8, 2008
    Assignee: Novartis AG
    Inventors: Donatienne Denni-Dischert, Andreas Floersheimer, Ernst Kuesters, Lukas Oberer, Gottfried Sedelmeier
  • Epothilone derivatives
    Publication number: 20060014796
    Abstract: The present invention relates to C4-demethyl-epothilones or C4-bisnor-epothilones of Formula (I), their pharmaceutical use, pharmaceutical composition containing the same and methods for their preparation.
    Type: Application
    Filed: December 22, 2003
    Publication date: January 19, 2006
    Inventors: Donatienne Denni-Dischert, Andreas Floersheimer, Ernst Kusters, Lukas Oberer, Gottfried Sedelmeier
  • Macrolides
    Patent number: 6124453
    Abstract: A novel class of macrolides in whichi) positions 2 to 6 inclusive of the macrocyclic ring are provided by a piperidazinyl carboxylic acid residue; and/orii) positions 7 to 9 inclusive of the macrocyclic ring are provided by an aromatic .alpha.-amino acid residue; and/oriii) positions 10 to 12 inclusive of the macrocyclic ring are provided by an aliphatic .alpha.-amino acid residue, preferably comprising two, or especially all three of the characteristic structural features i), ii) and iii), more especially a compound of formula IX ##STR1## is provided having immunosuppressant and antinflammatory properties and protected and ring-open forms thereof.
    Type: Grant
    Filed: December 24, 1996
    Date of Patent: September 26, 2000
    Assignee: Novartis AG
    Inventors: Theodor Fehr, Lukas Oberer, Valerie Quesniaux Ryffel, Jean-Jacques Sanglier, Walter Schuler
  • Tetracyclic triterpenes
    Patent number: 5852005
    Abstract: The present invention relates to 17 .alpha.-dammara compounds having immunosuppressant and antiinflammatory activity and which are useful as pharmaceuticals, particularly for use as immunosuppressant and antiinflammatory agents. Specific 17 .alpha.-dammara compounds are included per se, for example the compound of formula IC, i.e. 17 .alpha.-23-(E)-dammara-20, 23-dien-3.beta., 25-diol, which may be obtained from the flour of the shoots of the Palmyrah palm, Borassus flabellifer L. In addition, processes for the synthesis of this and other dammara compounds and intermediates thereof are described.
    Type: Grant
    Filed: January 24, 1997
    Date of Patent: December 22, 1998
    Assignee: Novartis AG
    Inventors: Peter Hiestand, Reto Naef, Hans-Ulrich Naegeli, Lukas Oberer, Laszlo Revesz, Hans-Jorg Roth